The novel glycolipid RC-552 attenuates myocardial stunning and reduces infarct size in dogs. [electronic resource]
Producer: 20000809Description: 1327-39 p. digitalISSN:- 0022-2828
- Animals
- Antibodies, Monoclonal
- Blood Flow Velocity
- Dogs
- Dose-Response Relationship, Drug
- Enzyme-Linked Immunosorbent Assay
- Female
- Flow Cytometry
- Glycolipids -- chemistry
- Hemodynamics
- Humans
- Intercellular Adhesion Molecule-1 -- biosynthesis
- Interleukin-6 -- biosynthesis
- Interleukin-8 -- biosynthesis
- L-Selectin -- blood
- Leukocytes, Mononuclear -- drug effects
- Lipid A -- analogs & derivatives
- Lipopolysaccharides -- pharmacology
- Male
- Myocardial Infarction -- drug therapy
- Myocardial Stunning -- drug therapy
- Neutrophils -- drug effects
- Rabbits
- Tumor Cells, Cultured
- Tumor Necrosis Factor-alpha -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.